DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on October 6, 2004; DOI: 10.1124/dmd.104.001891


0090-9556/05/3301-131-138$20.00
DMD 33:131-138, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001891v1
33/1/131    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, E. R.
Right arrow Articles by Osawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, E. R.
Right arrow Articles by Osawa, Y.

TIME-DEPENDENT INHIBITION AND TETRAHYDROBIOPTERIN DEPLETION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE CAUSED BY CIGARETTES

Ezra R. Lowe, Andrew C. Everett, Anthony J. Lee, Miranda Lau, Anwar Y. Dunbar, Vladimir Berka, Ah-lim Tsai, and Yoichi Osawa

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (E.R.L., A.C.E., A.J.L., M.L., A.Y.D., Y.O.); and Department of Internal Medicine, University of Texas, Health Sciences Center, Houston, Texas (V.B., A.-L.T.)

Smoking causes a dysfunction in endothelial nitric-oxide synthase (eNOS), which is ameliorated, in part, by administration of tetrahydrobiopterin (BH4). The exact mechanism by which the nitric oxide deficit occurs is unknown. We have previously shown that aqueous extracts of chemicals in cigarettes (CE) cause the suicide inactivation of neuronal NO synthase (nNOS) by interacting at the substrate-binding site. In the current study, we have found that CE directly inactivates eNOS by a process that is not affected by the natural substrate L-arginine and is distinct from the mechanism of inactivation of nNOS. We discovered that CE causes a time-, concentration-, and NADPH-dependent inactivation of eNOS in an in vitro system containing the purified enzyme, indicating a metabolic component to the inactivation. The CE-treated eNOS but not nNOS was nearly fully reactivated upon incubation with excess BH4, suggesting that BH4 depletion is a potential mechanism of inactivation. Moreover, in the presence of CE, eNOS catalyzed the oxidation of BH4 to dihydrobiopterin and biopterin by a process attenuated by high concentrations of superoxide dismutase but not catalase. We speculate that a redox active component in CE, perhaps a quinone compound, causes oxidative uncoupling of eNOS to form superoxide, which in turn oxidizes BH4. The discovery of a direct inactivation of eNOS by a compound(s) present in tobacco provides a basis not only for further study of the mechanisms responsible for the biological effects of tobacco but also a search for a potentially novel inactivator of eNOS.


Address correspondence to: Yoichi Osawa, Department of Pharmacology, University of Michigan Medical School, 1301 Medical Science Research Building III, Ann Arbor, MI 48109-0632. E-mail: osawa{at}umich.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. T. Gao, L. J. Roman, P. Martasek, S. P. Panda, Y. Ishimura, and B. S. S. Masters
Oxygen Metabolism by Endothelial Nitric-oxide Synthase
J. Biol. Chem., September 28, 2007; 282(39): 28557 - 28565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. C. Reddy, Y. Hao, S.-H. Lee, S. R. Gangireddy, C. Owyang, and M. J. DiMagno
Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders?
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G112 - G120.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa
Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo
Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. M. Shaw, D. M. Iovannisci, W. Yang, R. H. Finnell, S. L. Carmichael, S. Cheng, and E. J. Lammer
Endothelial Nitric Oxide Synthase (NOS3) Genetic Variants, Maternal Smoking, Vitamin Use, and Risk of Human Orofacial Clefts
Am. J. Epidemiol., December 15, 2005; 162(12): 1207 - 1214.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.